Rat Anti-Slc17a8 Recombinant Antibody (clone rtN34/34.2) (CAT#: VS-0422-LC108)

1. Q 1: What are the primary applications of the Anti-Slc17a8 Recombinant Antibody in research?

   A: The Anti-Slc17a8 Recombinant Antibody is prominently used in neuroscience research. It can be employed in immunocytochemistry, Western blot, and immunofluorescence applications. Its high specificity against the Slc17a8 protein in rats, T. californica, and mice makes it an invaluable tool for visualizing vesicular glutamate transporter 3 (VGLUT3) expression patterns in different studies. This is crucial for understanding synaptic transmission mechanisms and related neurological pathways.

2. Q 2: What diseases can be studied using the Anti-Slc17a8 Recombinant Antibody?

   A: This antibody is particularly useful for studying autosomal dominant 25 deafness and autosomal dominant non-syndromic sensorineural deafness type Dfna. The Slc17a8 gene's involvement in glutamate neurotransmission makes this study vital for understanding hearing impairments and related auditory conditions at a molecular level.

3. Q 3: What pathways are associated with the Slc17a8 protein targeted by this antibody?

   A: The Slc17a8 protein is part of neurotransmitter vesicle trafficking pathways, particularly important in glutamatergic synapse function. Studying these pathways helps elucidate mechanisms underlying synaptic signaling and disorders related to impaired neurotransmitter release.

View the frequently asked questions answered by Creative Biolabs Support.